Effects of SN-38 (an active metabolite of CPT-11) on responses of human and rodent cells to irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 4, 1998, Pages 785-788

  Sasai, K ^a   Guo, G Z ^a   Shibuya, K ^a   Oya, N ^a   Shibata, T ^a   Nagata, Y ^a   Hiraoka, M ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Camptothecin; CPT 11; Radiation; SN 38; Topoisomerase I

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; DNA TOPOISOMERASE; IRINOTECAN;

ANIMAL CELL; CELL SURVIVAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CYTOTOXICITY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RADIOSENSITIVITY; RAT; SURVIVAL RATE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHO CELLS; CRICETINAE; DNA TOPOISOMERASES, TYPE I; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HUMANS; TUMOR CELLS, CULTURED;

EID: 0031742795     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00326-5     Document Type: Conference Paper

References (13)

1. Ng C.E., Bussey A.M., Raaphorst G.P. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines. Int J Radiat Biol. 66:1994;49-57.
2. Rivory L.P. Irinotecan (CPT-11) a brief overview . Clin Exp Pharmacol Physiol. 23:1996;1000-1004.
3. Yoshida A., Ueda T., Wano Y., Nakamura T. DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells. Jpn J Cancer Res. 84:1993;566-573.
4. Falk S.J., Smith P.J. DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells. Int J Radiat Biol. 61:1992;749-757.
5. Tamura K., Takada M., Kawase I., Tada T., Kudoh S., Okishio K., Fukuoka M., Yamaoka N., Fujiwara Y., Yamakido M. Enhancement of tumor radio-response by irinotecan in human lung tumor xenograft. Jpn J Cancer Res. 88:1997;218-223.
6. Mattern M.R., Hofmann G.A., McCabe F.L., Johnson R.K. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Cancer Res. 51:1991;5813-5816.
7. Kim J.H., Kim S.H., Kolozsvary A., Khil M.S. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. Int J Radiat Oncol Biol Phys. 22:1992;515-518.
8. Boothman D.A., Wang M., Schea R.A., Burrows H.L., Strickfaden S., Owens J.K. Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells. Int J Radiat Oncol Biol Phys. 24:1992;939-948.
9. Musk S.R.R., Steel G.G. The inhibition of cellular recovery in human tumor cells by inhibitiors of topoisomerase. Br J Cancer. 62:1990;364-367.
10. Jansen W.J., Zwart B., Hulscher S.T., Giaccone G., Pinedo H.M., Boven E. CPT-11 in human colon-cancer cell line and xenografts characterization of cellular sensitivity determinants . Int J Cancer. 70:1997;335-340.
11. Omura M., Torigoe S., Kubota N. SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiother Oncol. 43:1997;197-201.
12. Shibuya K. Unpublished work.
13. Hennequin C., Giocanti N., Balosso J., Favaudon V. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and Hela cells. Cancer Res. 54:1994;1720-1728.